Alnylam Pharma (ALNY) Misses Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 227.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $227.66 | 52 Week High | $109.10 | |||
| Open | $227.66 | 52 Week Low | $31.38 | |||
| Day High | $227.66 | P/E | N/A | |||
| Day Low | $227.66 | EPS | $-1.45 | |||
| Volume | 532 | |||||
